Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Ebs crawled date : 2021 - 05 - 03 save search
New Data from Vaxart Oral COVID-19 Vaccine Phase I Study Suggests Broad Cross-Reactivity against Other Coronaviruses
Published: 2021-05-03 (Crawled : 21:00) - globenewswire.com
EBS | News | $2.16 5.88% 0.0% 1.4M
|
Health Technology
|
| O: -1.2%
H: 0.62%
C: -2.88%
VXRT | News | $0.7625 0.91% 0.9% 940K
|
Health Technology
|
| O: 18.45%
H: 0.53%
C: -7.79%
covid vaccine
Vaxart Reports First Quarter 2021 Financial Results and Provides Business Update
Published: 2021-05-03 (Crawled : 13:00) - globenewswire.com
EBS | News | $2.16 5.88% 0.0% 1.4M
|
Health Technology
|
| O: 0.61%
H: 0.96%
C: 0.39%
VXRT | News | $0.7625 0.91% 0.9% 940K
|
Health Technology
|
| O: -7.51%
H: 5.92%
C: -19.56%
financial results results
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.